| |
| |
|
| Insider
Information: |
Civik Thomas |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
213,686 |
|
|
Indirect Shares
|
15,700 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
229,386 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foundation Medicine, Inc. |
FMI |
Chief Commercial Officer |
2018-07-31 |
0 |
2018-01-01 |
0 |
Premium* |
|
|
Five Prime Therapeutics Inc |
FPRX |
President and CEO, Dir... |
2021-04-16 |
0 |
2020-04-13 |
0 |
Premium* |
|
|
Repare Therapeutics Inc. |
RPTX |
Director |
2021-11-16 |
7,500 |
2021-11-16 |
0 |
Premium* |
|
|
Pyxis Oncology, Inc. |
PYXS |
Director |
2023-03-24 |
206,186 |
2023-03-24 |
15,700 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PYXS |
Pyxis Oncology, Inc. |
Director |
– • – |
2023-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
139,355 |
206,186 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
|
• • – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
66,831 |
66,831 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Director |
– • – |
2021-11-18 |
4 |
B |
$12.74 |
$200,018 |
I/I |
15,700 |
15,700 |
2.1 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-11-16 |
4 |
B |
$28.08 |
$210,600 |
D/D |
7,500 |
7,500 |
2.39 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2021-04-16 |
4 |
D |
$38.00 |
$2,620,898 |
D/D |
(68,971) |
0 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2021-04-09 |
4 |
D |
$37.94 |
$420,679 |
D/D |
(11,088) |
68,971 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2020-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2018-07-31 |
4 |
D |
$137.00 |
$4,578,677 |
D/D |
(33,421) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2018-01-01 |
4 |
A |
$68.20 |
$2,279,312 |
D/D |
33,421 |
33,421 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
